Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study - Wikidata - awgldk - TriplyDB

Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study

Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study

http://www.wikidata.org/entity/Q33301961

about

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs Mass casualties and health care following the release of toxic chemicals or radioactive material--contribution of modern biotechnology Biomarkers in chronic obstructive pulmonary disease: confusing or useful?Gene promoter methylation is associated with lung function in the elderly: the Normative Aging Study Chronic obstructive pulmonary disease: effects beyond the lungs.The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema.Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection.The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.Repression of CC16 by cigarette smoke (CS) exposure.Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA.Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease.Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study).Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease.Bone mineral density among elderly patients with chronic obstructive pulmonary disease patients in India.Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice.Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases.Unifying thoracic biomarkers: surfactant protein-D and beyond.Chemotherapeutic treatment reduces circulating levels of surfactant protein-D in children with acute lymphoblastic leukemia.[Preoperatiove Airway Bacterial Colonization: the Missing Link between Non-small Cell Lung Cancer Following Lobectomy and Postoperative Pneumonia?]Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPD.Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.Research Highlights: Pulling out novel COPD genes from the 'gray zone' of genome-wide association studies.Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

P2860

Q26766294-77659B53-9172-4CC3-AB00-9377E77D993F Q27001184-07CF7355-2A75-46B4-91A5-3784B781530B Q27690280-E652D00C-A906-45B5-9F21-244A3FF24FCC Q28383778-2B2B7A96-D8A9-4DC9-A4CA-B68D455B6A36 Q33543733-749CBD8D-C304-4D0C-9CCB-7E3EDC30B047 Q33740494-88C75F5B-878A-4A2C-80E3-572F1E61345B Q33876864-168E55D9-6010-4DED-9E1D-A7E971B317FF Q34119539-4FEB1ADF-DB23-49CE-A12C-20E769EE8F13 Q34228984-C0A8CA15-DF8D-4418-84DC-56FD54090B1A Q34636461-A87D862A-13A9-4DF5-96CB-6E2A4385A494 Q34667220-3A10F0F2-3C24-47FB-AC3E-E442ABF590D7 Q34676003-AE562910-F148-4901-B708-305C23114B03 Q34676410-4313B48E-061D-4222-A41D-6B7B173A0C2F Q34704441-3183D88B-2937-4517-8BC5-6ED9928243F0 Q34985449-30523863-1D8B-4B27-B3F9-B16908B7B841 Q35032256-68665334-0E7D-4214-9D9D-8E5C780D19DD Q35387845-8B9F2F07-4A13-410D-9D9D-1D0A5C7AE857 Q35935690-13B57F12-E240-4CD5-AD79-E0614E3800A7 Q36000101-018C5145-55EC-469C-8127-A9BC1C640288 Q36060275-63F4F11F-9720-4C36-823C-8617CB2592AE Q36268923-08803BD1-0C5D-4611-8D8A-1B09ABC3AEEB Q36288980-9C436EA2-9E91-4A0A-AEC4-B5C86594C293 Q36300138-1457D396-96F6-4D27-8721-797C01F592B1 Q36308003-AAB51EE8-BE3E-4FC3-A507-B43C13C46292 Q36897307-A2E8FAB0-9941-4149-8E00-0CA8A9A7FFA4 Q37443257-D80C760F-5151-4282-9852-E58C311602E1 Q37490124-E2976CDF-1344-4055-BB5F-1A732FCF3CA0 Q37636173-FA530221-2D53-4E1F-9D75-B777A30EC91B Q37964807-C5E1F4F5-BE95-4845-BB15-E29F1F5C0C0E Q37989564-861E1242-D9E0-4474-B052-5C26A62A85A6 Q37997815-9C591D78-3C6E-48CC-A486-C6D3005737CA Q39352647-1BA0D7EC-6EF4-40CF-AB41-8E515EDD9193 Q40238291-704D250F-3041-4DBB-84D6-BD57499F8BDC Q42759714-2CE4E839-D5BF-4647-903C-05ECD1621D80 Q47395738-911BFE21-7495-45D6-B4F5-7F7DDCEB89FF Q47560999-A016CD72-6D87-4497-AAF3-663DD066E2F4 Q54484018-84FEE20F-A1B1-4F73-8AE2-5445F941229E Q55269439-91AD1E70-21C5-452F-984D-1BAC011F84A1

P2860

Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study

http://www.wikidata.org/entity/Q33301961

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Circulating surfactant protein ...... utcomes in COPD: a pilot study

@ast

Circulating surfactant protein ...... utcomes in COPD: a pilot study

@en

Circulating surfactant protein ...... tcomes in COPD: a pilot study.

@nl

type

label

Circulating surfactant protein ...... utcomes in COPD: a pilot study

@ast

Circulating surfactant protein ...... utcomes in COPD: a pilot study

@en

Circulating surfactant protein ...... tcomes in COPD: a pilot study.

@nl

prefLabel

Circulating surfactant protein ...... utcomes in COPD: a pilot study

@ast

Circulating surfactant protein ...... utcomes in COPD: a pilot study

@en

Circulating surfactant protein ...... tcomes in COPD: a pilot study.

@nl

P1433

Q33301961-F9C7AB19-87E8-486D-8143-E62A4891F251

P1476

Q33301961-7BE1A413-728D-4AE8-91F5-954CB3588503

P2093

Q33301961-3C4D25BE-406E-4DD3-B05E-EB89C852656A

Q33301961-5F6037E6-1CBE-4B56-8A7F-8DB04D3A4D31

Q33301961-A411B828-A320-49DC-817F-1392B237301B

Q33301961-EA902B4D-E90D-4E25-A1C7-8DF097650CFA

P2860

Q33301961-433C06F1-13BD-4DB4-8795-F1670E8CA9BC

Q33301961-5868D3FF-57AA-44EB-A21F-CC6C71C33226

Q33301961-6613AEC4-2E65-44F6-9C3B-B04844043E9B

Q33301961-6B2C297B-FB85-4FD3-8DDA-5C97D3F568A8

Q33301961-84A74F89-4DFE-4FC9-8209-24F35ACE9377

Q33301961-8D9490A8-0B3C-47C1-BA2C-A6F02AED31C2

Q33301961-8EBB94AD-CB21-4ABC-88DF-A9F0EDAB1E97

Q33301961-9DF2081C-A7C8-4EC1-9245-742B28CB29B9

Q33301961-A88E2F7A-1039-4352-A950-AB1D5A9EAEDB

Q33301961-B1394F6D-BE5B-47DB-8C1D-255B84668B52

P2888

Q33301961-10B3DA5A-5DB7-4212-8464-84786C4760A6

P304

Q33301961-B8EF71C6-EC22-4628-9F62-70ADF25E5CFC

P31

Q33301961-8ACBB606-B133-4EE6-8C37-65E1B8B86386

P356

Q33301961-877BC4B0-7818-4727-8A55-4429DA152784

P478

Q33301961-68339123-786D-48B3-9875-A65B3EC99E0D

P577

Q33301961-974378FB-55E1-4145-9D6C-BEF3C68B818A

P5875

Q33301961-079AEB23-5677-4FF9-826E-A0FBE25CC1D4

P6179

Q33301961-EC37DC85-1DA6-4E74-884D-B97587E7642B

P698

Q33301961-5903425B-9C97-4C46-BF8C-A25E072335C4

P921

Q33301961-3BC51059-F0A6-43C9-B433-29030EA567DF

P932

Q33301961-9CECC3CE-FD97-456E-8EF6-BCBEAFD2BB9A

P356

P1433

BMC Pulmonary Medicine

P1476

Circulating surfactant protein ...... utcomes in COPD: a pilot study

@en

P2093

Don D Sin

http://www.w3.org/2001/XMLSchema#string

Rochelle Leung

http://www.w3.org/2001/XMLSchema#string

Sf Paul Man

http://www.w3.org/2001/XMLSchema#string

Wen Q Gan

http://www.w3.org/2001/XMLSchema#string

P2860

C-reactive protein: a critical update

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

Markers of exacerbation severity in chronic obstructive pulmonary disease

Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.

COPD: current therapeutic interventions and future approaches.

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.

What does minor elevation of C-reactive protein signify?

Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects.

Surfactant protein-D, a mediator of innate lung immunity, alters the products of nitric oxide metabolism.

Prognostic value of surfactant proteins A and D in patients with acute lung injury.

P2888

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2466-7-13

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5921993

http://www.w3.org/2001/XMLSchema#string

P6179

1045941106

http://www.w3.org/2001/XMLSchema#string

P698

17922919

http://www.w3.org/2001/XMLSchema#string

P921

P932

2096624

http://www.w3.org/2001/XMLSchema#string